{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T16:53:19Z","timestamp":1676479999179},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:00:00Z","timestamp":1344556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00115-012-3631-5","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T08:56:10Z","timestamp":1344502570000},"page":"1582-1589","source":"Crossref","is-referenced-by-count":1,"title":["Repetitive impulsassoziierte Verhaltensst\u00f6rungen beim Morbus Parkinson"],"prefix":"10.1007","volume":"83","author":[{"given":"R.","family":"Katzenschlager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.S.","family":"Goerlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"van Eimeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"key":"3631_CR1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.22439","volume":"24","author":"Bach","year":"2009","unstructured":"Bach JP, Oertel WH, Dodel R et al (2009) Treatment of hypersexuality in Parkinson\u2019s disease with carbamazepine: a case report. Mov Disord 24:1241\u20131242","journal-title":"Mov Disord"},{"key":"3631_CR2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mds.23395","volume":"26","author":"Benincasa","year":"2011","unstructured":"Benincasa D, Pellicano C, Fanciulli A et al (2011) Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson\u2019s disease. Mov Disord 26:355\u2013357","journal-title":"Mov Disord"},{"key":"3631_CR3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.parkreldis.2007.11.008","volume":"14","author":"Bermejo","year":"2008","unstructured":"Bermejo PE (2008) Topiramate in managing impulse control disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord 14:448\u2013449","journal-title":"Parkinsonism Relat Disord"},{"key":"3631_CR4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","volume":"39","author":"Cilia","year":"2010","unstructured":"Cilia R, Ko JH, Cho SS et al (2010) Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis 39:98\u2013104","journal-title":"Neurobiol Dis"},{"key":"3631_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","volume":"19","author":"Evans","year":"2004","unstructured":"Evans AH, Katzenschlager R, Paviour D et al (2004) Punding in Parkinson\u2019s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397\u2013405","journal-title":"Mov Disord"},{"key":"3631_CR6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mds.22898","volume":"25","author":"Evans","year":"2010","unstructured":"Evans AH, Lawrence AD, Cresswell SA et al (2010) Compulsive use of dopaminergic drug therapy in Parkinson\u2019s disease: reward and anti-reward. Mov Disord 25:867\u2013876","journal-title":"Mov Disord"},{"key":"3631_CR7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","volume":"65","author":"Evans","year":"2005","unstructured":"Evans AH, Lawrence AD, Potts J et al (2005) Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65:1570\u20131574","journal-title":"Neurology"},{"key":"3631_CR8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.20822","volume":"59","author":"Evans","year":"2006","unstructured":"Evans AH, Pavese N, Lawrence AD et al (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59:852\u2013858","journal-title":"Ann Neurol"},{"key":"3631_CR9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00415-010-5817-8","volume":"258","author":"Fasano","year":"2011","unstructured":"Fasano A, Ricciardi L, Pettorruso M et al (2011) Management of punding in Parkinson\u2019s disease: an open-label prospective study. J Neurol 258:656\u2013660","journal-title":"J Neurol"},{"key":"3631_CR10","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/mds.22652","volume":"24","author":"Gerschlager","year":"2009","unstructured":"Gerschlager W, Bloem BR (2009) Managing pathological gambling in Parkinson\u2019s disease with enteral levodopa\/carbidopa infusions. Mov Disord 24:1858\u20131860","journal-title":"Mov Disord"},{"key":"3631_CR11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.parkreldis.2011.03.003","volume":"17","author":"Hicks","year":"2011","unstructured":"Hicks CW, Pandya MM, Itin I et al (2011) Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 17:379\u2013381","journal-title":"Parkinsonism Relat Disord"},{"key":"3631_CR12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0038-1627134","volume":"27","author":"Katzenschlager","year":"2008","unstructured":"Katzenschlager R (2008) St\u00f6rungen von Verhalten und Impulskontrolle beim Morbus Parkinson. Nervenheilkunde 27:721\u2013727","journal-title":"Nervenheilkunde"},{"key":"3631_CR13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1590\/S0004-282X2006000600026","volume":"64","author":"Kummer","year":"2006","unstructured":"Kummer A, Maia DP, Salgado JV et al (2006) Dopamine dysregulation syndrome in Parkinson\u2019s disease: case report. Arq Neuropsiquiatr 64:1019\u20131022","journal-title":"Arq Neuropsiquiatr"},{"key":"3631_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YCO.0b013e32831575d9","volume":"22","author":"Leung","year":"2009","unstructured":"Leung KS, Cottler LB (2009) Treatment of pathological gambling. Curr Opin Psychiatry 22:69\u201374","journal-title":"Curr Opin Psychiatry"},{"key":"3631_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","volume":"23","author":"Mamikonyan","year":"2008","unstructured":"Mamikonyan E, Siderowf AD, Duda JE et al (2008) Long-term follow-up of impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:75\u201380","journal-title":"Mov Disord"},{"key":"3631_CR16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/mds.21296","volume":"22","author":"Miyasaki","year":"2007","unstructured":"Miyasaki JM, Al Hassan K, Lang AE et al (2007) Punding prevalence in Parkinson\u2019s disease. Mov Disord 22:1179\u20131181","journal-title":"Mov Disord"},{"key":"3631_CR17","doi-asserted-by":"crossref","first-page":"e29768","DOI":"10.1371\/journal.pone.0029768","volume":"7","author":"Moum","year":"2012","unstructured":"Moum SJ, Price CC, Limotai N et al (2012) Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome. PLoS ONE 7:e29768","journal-title":"PLoS ONE"},{"key":"3631_CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","volume":"67","author":"Rabinak","year":"2010","unstructured":"Rabinak CA, Nirenberg MJ (2010) Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 67:58\u201363","journal-title":"Arch Neurol"},{"key":"3631_CR19","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mds.23177","volume":"25","author":"Rotondo","year":"2010","unstructured":"Rotondo A, Bosco D, Plastino M et al (2010) Clozapine for medication-related pathological gambling in Parkinson disease. Mov Disord 25:1994\u20131995","journal-title":"Mov Disord"},{"key":"3631_CR20","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/mds.21118","volume":"21","author":"Silveira-Moriyama","year":"2006","unstructured":"Silveira-Moriyama L, Evans AH, Katzenschlager R et al (2006) Punding and dyskinesias. Mov Disord 21:2214\u20132217","journal-title":"Mov Disord"},{"key":"3631_CR21","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"Steeves","year":"2009","unstructured":"Steeves TD, Miyasaki J, Zurowski M et al (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132:1376\u20131385","journal-title":"Brain"},{"key":"3631_CR22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","volume":"68","author":"Thomas","year":"2010","unstructured":"Thomas A, Bonanni L, Gambi F et al (2010) Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 68:400\u2013404","journal-title":"Ann Neurol"},{"key":"3631_CR23","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1038\/npp.2009.124","volume":"34","author":"Eimeren","year":"2009","unstructured":"Eimeren T van, Ballanger B, Pellecchia G et al (2009) Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson\u2019s disease? Neuropsychopharmacology 34:2758\u20132766","journal-title":"Neuropsychopharmacology"},{"key":"3631_CR24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181fc27fa","volume":"75","author":"Eimeren","year":"2010","unstructured":"Eimeren T van, Pellecchia G, Cilia R et al (2010) Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 75:1711\u20131716","journal-title":"Neurology"},{"key":"3631_CR25","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","volume":"66","author":"Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M et al (2006) Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66:1750\u20131752","journal-title":"Neurology"},{"key":"3631_CR26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","volume":"24","author":"Voon","year":"2011","unstructured":"Voon V, Mehta AR, Hallett M (2011) Impulse control disorders in Parkinson\u2019s disease: recent advances. Curr Opin Neurol 24:324\u2013330","journal-title":"Curr Opin Neurol"},{"key":"3631_CR27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589\u2013595","journal-title":"Arch Neurol"},{"key":"3631_CR28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K et al (2012) Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s Disease\u2013Rating Scale. Mov Disord 27:242\u2013247","journal-title":"Mov Disord"},{"key":"3631_CR29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","volume":"68","author":"Weintraub","year":"2010","unstructured":"Weintraub D, Sohr M, Potenza MN et al (2010) Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol 68:963\u2013968","journal-title":"Ann Neurol"},{"key":"3631_CR30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/mds.20501","volume":"20","author":"Witjas","year":"2005","unstructured":"Witjas T, Baunez C, Henry JM et al (2005) Addiction in Parkinson\u2019s disease: impact of subthalamic nucleus deep brain stimulation. Mov Disord 20:1052\u20131055","journal-title":"Mov Disord"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-012-3631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-012-3631-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-012-3631-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T17:34:52Z","timestamp":1562088892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-012-3631-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3631"],"URL":"https:\/\/doi.org\/10.1007\/s00115-012-3631-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]}}}